REQUEST A DEMO
Total
USD $0.00
Search more companies

Northern Synthesis SIA (Latvia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Northern Synthesis SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Northern Synthesis SIA is an enterprise located in Latvia, with the main office in Riga. It operates in the Pharmaceutical Preparation Manufacturing industry. Northern Synthesis SIA was incorporated on September 05, 1995. There are currently 51 (2023) people employed by Northern Synthesis SIA. From the latest financial highlights, Northern Synthesis SIA reported a net sales revenue drop of 35.43% in 2024. During that time, Northern Synthesis SIA’s total assets decreased by 0.16%. Northern Synthesis SIA’s net profit margin decreased by 1.86% in 2024.

Headquarters
Gertrudes iela 1517
Riga; Riga; Postal Code: 1011

Contact Details: Purchase the Northern Synthesis SIA report to view the information.

Basic Information
Total Employees:
Purchase the Northern Synthesis SIA report to view the information.
Registered Capital:
Purchase the Northern Synthesis SIA report to view the information.
Financial Auditors:
Purchase the Northern Synthesis SIA report to view the information.
Incorporation Date:
September 05, 1995
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Northern Synthesis SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-35.43%
Total operating revenue
-34.35%
Operating profit (EBIT)
-45.25%
EBITDA
-45.25%
Net Profit (Loss) for the Period
-48.8%
Total Assets
-0.16%
Total Equity
8.24%
Operating Profit Margin (ROS)
-1.45%
Net Profit Margin
-1.86%
Return on Equity (ROE)
-8.48%
Quick Ratio
-0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?